| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |







From the Renal Immunopathology Laboratory,* Associazione Nuova Nefrologia, c/o S. Carlo Hospital, Milano, Italy; the Institute of Clinical Pathology,
Vienna University, Vienna, Austria; and the Klinische Biochemie,
Medizinische Poliklinik, and the Institut für Veterinärpathologie,
University of Munich, Munich, Germany
| Abstract |
|---|
|
|
|---|
Rabphilin-3A is a synaptic vesicle protein, first discovered as a binding partner and effector of Rab3A, a member of the Rab family of guanosine triphosphate (GTP) hydrolases (G proteins).7
Rabphilin-3A binds to Rab3A only in its GTP-bound state, and the complex is required for the correct docking of synaptic vesicles to their target membrane.8
Binding of rabphilin-3A to Rab3A occurs via the amino (NH2)-terminal half of rabphilin-3A. In absence of Rab3A, rabphilin-3A can bind to the cytoskeletal protein
-actinin increasing its actin filament bundling activity.9
The carboxy (COOH) terminus of rabphilin-3A contains two C2 (protein kinase C-homology-2) domains (C2A and C2B) that bind to calcium and phospholipids and are homologous to the C2 domains of synaptotagmin.10
In addition, the C2 domains can bind to another cytoskeletal protein, ß-adducin, an actin-binding molecule that acts in the assembly of spectrin-actin complexes at the plasma membrane.11
These biochemical properties of rabphilin-3A, in particular its ability to bind calcium, phospholipids, and cytoskeletal proteins, and the demonstration of the Rab3A-rabphilin-3A complex in synapses and neuroendocrine cells, prompted our attention in considering these proteins as possible players in podocyte biology.
Here we demonstrate that rabphilin-3A and Rab3A are present in the kidney and specifically localize in podocytes. Moreover, their expression is altered in mouse and human proteinuric diseases, suggesting their possible role in glomerulopathies.
| Materials and Methods |
|---|
|
|
|---|
Normal kidney and normal brain tissue were obtained from 3-month-old animals, namely five Sprague-Dawley rats, five 129/SVLMJ mice, four CD-1 mice [the wild-type (WT) littermates of growth hormone (GH)-transgenics; average weight, 43.6 ± 2.0 g; average urine albumin/urine creatinine, 28.0 ± 10.2 µg/mg]. Normal human kidney was from normal areas of 10 human kidneys uninvolved by neoplasia from tumor nephrectomies. Diseased kidney samples were from four 3-month-old GH-transgenic mice (average weight, 70.6 ± 5.2 g; average urine albumin/urine creatinine, 8560 ± 5838 µg/mg)12 and 15 biopsies of patients with proteinuric diseases (five minimal change disease, five primary membranous nephropathy, five primary focal and segmental glomerulosclerosis).
Tissue samples for light microscopy were fixed in 4% buffered paraformaldehyde and embedded in paraffin. Routine stainings were performed on 2-µm-thick sections according to standard techniques. For immunohistochemistry, unfixed renal tissue was embedded in OCT (optimum cutting temperature cryoembedding matrix) (Miles Scientific, Naperville, IL), snap-frozen in a mixture of isopentane and dry-ice, and stored at -80°C. Subsequently, 5-µm kidney sections and 8-µm brain sections were placed on slides, fixed in cold acetone, and stored at -20°C until immunostained. For immunogold electron microscopy, normal rat tissue was fixed in a mixture of formaldehyde, glutaraldehyde, and phosphate buffer, soaked in glucose and frozen, or alternatively embedded in Lowicril K4M resin (Electron Microscopy Sciences, Società Italiana Chimici, Rome, Italy), as previously described.13 Glomeruli from the remaining mouse and rat tissue were separated by filtering through 200-, 100-, and 70-µm sieves, whereas human glomeruli were manually microdissected from the normal kidneys. All glomeruli were alternatively stored at -20°C after dipping in RNA-Later (Ambion Inc., Austin, TX) for mRNA extraction, or at -80°C until proteins were extracted.
Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)
RNA was isolated from mouse, rat, and human glomeruli and from rat and mouse brain using the RNAqueous kit (Ambion Inc.). All procedures were performed according to the manufacturers protocol: briefly, the extracted glomeruli were homogenized in lysing/binding solution, RNA was isolated from the lysate using a glass fibers filter that can bind specifically RNA and eluted from the filter using an elution buffer. Subsequently RNA was treated with DNase to remove traces of DNA contamination. RNA quality was tested by the Agilent 2001 Bioanalyzer (Agilent Technologies Italia, Cernusco sul Naviglio, Milan, Italy). mRNA was then reverse-transcribed using the Omniscript Reverse Transcriptase kit (Qiagen Inc., Milan, Italy) with Oligo dT Primer p(DT)15 (Roche Diagnostic Corp., Indianapolis, IN).
PCR was performed using TaqPCR Core Kit (Qiagen) in combination with the primers listed in Tables 1 and 2
(tested for specificity with the Nucleotide Blast from the NCBI homepage http://www.ncbi.nlm.nih.gov/BLAST/). In each species, rabphilin-3A sequence amplification was obtained by two primer pairs selected from both the NH2 and C2 domain sequences. Given the homology among Rab3 isoforms (A, B, C, D), Rab3A primers were designed from nonoverlapping fragments and PCR was conducted in stringent conditions. For both rabphilin-3A and Rab3A, to confirm the amplification of the desired sequence, nested-PCR followed the first round of amplification.
|
Western Blot
Glomerular proteins from rat and mouse glomeruli were extracted by lysis with a detergent-based buffer. Total glomerular proteins (100 µg) were run on a 12% sodium dodecyl sulfate-polyacrylamide electrophoresis gel and transferred to a nitrocellulose membrane (HybondECL, Amersham Biosciences) by electroblotting. Membranes were stained with Ponceau Red to control for adequate transfer and equally loaded amounts. After blocking, each membrane was incubated with the following primary antibodies: polyclonal rabbit anti-rabphilin-3A (BD Transduction Laboratories, Milan, Italy) and polyclonal rabbit anti-Rab3A (Synaptic Systems, Goettingen, Germany) followed by the proper secondary antibody (horseradish peroxidase-linked sheep anti-rabbit) (Amersham Biosciences). Positive reaction products were identified by enhanced chemiluminescence (ECL, Amersham) and autoradiography. Positive controls were performed using a brain protein extract provided together with the polyclonal anti-rabphilin antibody from BD Transduction Laboratories. Negative controls were performed by loading buffer instead of proteins on the sodium dodecyl sulfate-polyacrylamide electrophoresis gel or by substituting buffer or proper control immunoglobulins (ie, immunoglobulins of the same class and at the same concentration of the primary antibody) (Zymed) for the primary antibody. Positive and negative controls were run concurrently.
Immunohistochemistry
Immunohistochemistry was performed on 5-µm-thick acetone-fixed kidney sections, on 8-µm-thick brain sections, and on 1-µm-thick semithin sections. Briefly, rat and human material were sequentially hydrated, incubated with the primary monoclonal mouse anti-rabphilin-3A (BD Transduction Laboratories) and monoclonal mouse anti-Rab3A (Synaptic Systems), then by the secondary fluorescein isothiocyanate-labeled or cyanine3 (Cy3)-labeled goat anti-mouse secondary antibody (Zymed, Histoline, Milan, Italy).
To avoid nonspecific staining, a direct immunofluorescence was performed in mouse specimens after directly conjugating the primary monoclonal antibodies with fluorescent markers (Alexa Fluor 488 and 568) using the Zenon One labeling kit (Molecular Probes Europe BV, Leiden, The Netherlands) according to the manufacturers instructions. Similarly, for double staining, a direct immunofluorescence was conducted using alternatively in sequence two of the following labeled monoclonals: mouse anti-rabphilin-3A, mouse anti-Rab3A, and the podocyte-specific mouse anti-synaptopodin (Progen Biotechnik GmbH, Heidelberg, Germany). Nuclear counterstaining was performed by 4',6-diamidino-2-phenyindole (Sigma Chimica, Milan, Italy). Analysis of double-staining and co-localization studies were conducted on digitized images by Q-Fluor software (Leica Italia, Milan, Italy).
Specificity of antibody labeling was demonstrated by the lack of staining after applying as primary antibody a monoclonal mouse anti-synaptotagmin (BD Transduction Laboratories), chosen because of the high homology of the C2 domains of synaptotagmin and rabphilin-3A, or after substituting proper control immunoglobulins (Zymed) for the primary antibody. Positive controls were performed by applying anti-rabphilin-3A and Rab-3A on brain sections. To test the immunoreactivity of the tissue, a monoclonal mouse anti-vimentin antibody (Zymed), that stains glomeruli and vessels, was also applied on kidney sections. Positive and negative controls were run concurrently. Slides were mounted with Vectashield aqueous mounting medium (Vector Laboratories, DBA Italia SRL, Milan, Italy).
A semiquantitative evaluation (0 = negative, 1 = mild positivity, 2 = intense positivity) of rabphilin-3A and Rab3A staining was performed in mouse WT and GH-transgenic animals by scoring 30 glomeruli per section. The same semiquantitative score was applied to evaluate Rab3A positivity in all human renal tissues on an average of 9.3 ± 1.7 glomeruli/biopsy.
Immunogold Electron Microscopy
An indirect immunogold labeling procedure was performed on ultrathin sections, as previously described.13 Briefly, after blocking, the material was incubated with the primary monoclonal mouse anti-rabphilin-3A, and monoclonal mouse anti-Rab3A, then by the secondary 10-nm gold-conjugated goat anti-mouse secondary antibody (Aurion, DBA, Milan, Italy). Specificity of antibody labeling was demonstrated by the lack of staining after applying as primary antibody a monoclonal mouse anti-synaptotagmin, or after substituting proper controlimmunoglobulins (Zymed) for the primary antibody. As positive controls, anti-rabphilin-3A and anti-Rab3A were applied on brain tissues. Furthermore, to test the reactivity of kidney tissue, a monoclonal mouse anti-synaptopodyn antibody (Zymed), that stains glomerular podocytes, was also applied. Positive and negative controls were run together.
| Results |
|---|
|
|
|---|
|
|
|
|
|
|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
Among these proteins, Rab3A and its effector rabphilin-3A seem to possess not only vesicle specificity, but also cell specificity, because they have been mainly found in the nervous system, where they are required for correct docking of synaptic vesicles to the target membrane. Also in our hands, confirming previous results,16 both proteins have shown a dot-like pattern of immunoreactivity especially evident in the granular layer of cerebellum, an area particularly rich in synapses. In neuroendocrine and endocrine cells Rab3A and rabphilin-3A are involved in processes of highly regulated exocytosis,17,18 although their precise role still needs to be completely clarified. The extensive conservation of both proteins from Caenorhabditis elegans to vertebrates19 implies that they play a critical role and is consistent with our finding of a similar expression in mouse, rat, and human.
When Rab3A is GTP-bound and recruits its specific effector rabphilin-3A, it is the effector that regulates the vesicle motility along cytoskeletal elements and mediates the docking to the acceptor membrane.20
Podocytes possess a well-developed cytoskeleton: F-actin localizes to the submembranous region and maintains the infrastructure of the membrane domains and their complex digitated shape by continuous remodeling.21
Not surprisingly, most of the newly discovered podocyte-associated proteins, such as nephrin and CD2-associated protein (CD2AP), have been found strictly connected to the actin cytoskeleton.1
Rabphilin-3A interacts at least with two cytoskeletal molecules,
-actinin and ß-adducin,9,11
both important, at least to our knowledge, for podocyte homeostasis.
-actinin (the isoform 4) is highly expressed in podocytes and has recently gained attention because its mutations have been found to associate with familial forms of focal and segmental glomerulosclerosis,22
demonstrating its essential role in the maintenance of podocyte integrity. Although the exact function of
-actinin in the podocyte is not known at present, the molecule has been recently proposed to participate in processes of exocytosis23
and endocytosis.24
As far as rabphilin-3A, it has been shown that binding to
-actinin is able to increase the actin bundling activity of
-actinin.9
Because the binding is inhibited by the GTP-bound form of Rab3A, the authors have hypothesized that, through switching the GTPase on and off and alternatively binding of rabphilin to Rab3A and
-actinin, these molecules behave like a timer that prepares vesicles for docking/fusion events by cytoskeletal reorganization. Further studies are needed to understand whether these processes are operative also in podocytes and whether they account for at least some of the cytoskeletal remodeling observed in normal glomeruli and altered in disease.
Adducin is an ubiquitously expressed calmodulin-binding protein, first purified from human erythrocyte cytoskeleton and from brain membranes.25
It localizes at spectrin-actin junctions in erythrocyte membrane skeletons and co-localizes with spectrin at sites of cell-cell contact in epithelial cells and in dendritic spines. Adducin is believed to promote association of spectrin with actin and its function is to cap the fast-growing ends of actin filaments. It exists in three isoforms,
, ß, and
: although
- and
-adducin are ubiquitous, ß-adducin is more restricted and tissue-specific and has been found especially in the brain.25
We have found ß-adducin expressed in normal podocytes and are currently studying a rat strain with a ß-adducin point mutation that is highly proteinuric (unpublished results), but the significance of ß-adducin-rabphilin-3A interaction remains to be fully analyzed even in the brain.
We know that Rab proteins confer specificity to vesicles.20 It is noteworthy that, among more than 60 Rab proteins discovered in mammals, most of them ubiquitous, podocytes possess Rab3A and its specific effector rabphilin-3A, which are expressed only in cells capable of highly regulated exocytosis. It has been well known that podocytes are involved in many glomerular functions and, apart from the maintenance of the filtration barrier, they are responsible for the turnover of glomerular basement membrane components and for the ability to produce a variety of cytokines and growth factors,26 but these activities still need to be fully analyzed. Our immunogold results seem to confirm the precise location of rabphilin-3A and Rab3A around foot process vesicles. As a consequence, we believe that our results should present a starting point for better understanding podocyte exocytotic functions. Furthermore, in murine and human proteinuric conditions the expression of these molecules can increase, supporting the idea that the Rab3A-rabphilin-3A complex can play a role not only in normal but also in damaged podocytes.
|
| Footnotes |
|---|
Supported by the European Union grant QLG1-2000-00619.
Accepted for publication May 12, 2003.
| References |
|---|
|
|
|---|
-actinin. J Biol Chem 1996, 271:31775-31778
-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000, 24:251-256[Medline]
This article has been cited by other articles:
![]() |
T.-H. Huang, H.-A. Shui, S.-M. Ka, B.-L. Tang, T.-K. Chao, J.-S. Chen, Y.-F. Lin, and A. Chen Rab 23 is expressed in the glomerulus and plays a role in the development of focal segmental glomerulosclerosis Nephrol. Dial. Transplant., October 16, 2008; (2008) gfn570v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Asanuma, K. N. Campbell, K. Kim, C. Faul, and P. Mundel Nuclear relocation of the nephrin and CD2AP-binding protein dendrin promotes apoptosis of podocytes PNAS, June 12, 2007; 104(24): 10134 - 10139. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Bertelli, M. Regoli, L. Fonzi, R. Occhini, S. Mannucci, L. Ermini, and P. Toti Nestin Expression in Adult and Developing Human Kidney J. Histochem. Cytochem., April 1, 2007; 55(4): 411 - 421. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J.M. Coward, G. I. Welsh, A. Koziell, S. Hussain, R. Lennon, L. Ni, J. M. Tavare, P. W. Mathieson, and M. A. Saleem Nephrin Is Critical for the Action of Insulin on Human Glomerular Podocytes Diabetes, April 1, 2007; 56(4): 1127 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Miyauchi, A. Saito, T. Karasawa, Y. Harita, K. Suzuki, H. Koike, G. D. Han, F. Shimizu, and H. Kawachi Synaptic Vesicle Protein 2B Is Expressed in Podocyte, and Its Expression Is Altered in Proteinuric Glomeruli J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2748 - 2759. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ricci, C. Iacobini, G. Oddi, L. Amadio, S. Menini, M. P. Rastaldi, A. Frasheri, F. Pricci, F. Pugliese, and G. Pugliese Role of TGF-{beta}/GLUT1 axis in susceptibility vs resistance to diabetic glomerulopathy in the Milan rat model Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1514 - 1524. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Rastaldi, S. Armelloni, S. Berra, N. Calvaresi, A. Corbelli, L. A. Giardino, M. Li, G. Q. Wang, A. Fornasieri, A. Villa, et al. Glomerular podocytes contain neuron-like functional synaptic vesicles FASEB J, May 1, 2006; 20(7): 976 - 978. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Cohen, A. Klingenhoff, A. Boucherot, A. Nitsche, A. Henger, B. Brunner, H. Schmid, M. Merkle, M. A. Saleem, K.-P. Koller, et al. Comparative promoter analysis allows de novo identification of specialized cell junction-associated proteins PNAS, April 11, 2006; 103(15): 5682 - 5687. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Plaisier, B. Mougenot, M. C. Verpont, C. Jouanneau, J. J. Archelos, R. Martini, D. Kerjaschki, and P. Ronco Glomerular Permeability Is Altered by Loss of P0, a Myelin Protein Expressed in Glomerular Epithelial Cells J. Am. Soc. Nephrol., November 1, 2005; 16(11): 3350 - 3356. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Cohen, P. P. Doran, S. M. Blattner, M. Merkle, G. Q. Wang, H. Schmid, P. W. Mathieson, M. A. Saleem, A. Henger, M. P. Rastaldi, et al. Sam68-Like Mammalian Protein 2, Identified by Digital Differential Display as Expressed by Podocytes, Is Induced in Proteinuria and Involved in Splice Site Selection of Vascular Endothelial Growth Factor J. Am. Soc. Nephrol., July 1, 2005; 16(7): 1958 - 1965. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |